Rchr
J-GLOBAL ID:200901000039588380   Update date: Nov. 05, 2024

KOBAYASHI Kunihiko

コバヤシ クニヒコ | KOBAYASHI Kunihiko
Affiliation and department:
Job title: Professor
Homepage URL  (1): http://homepage3.nifty.com/care-notebook/
Research theme for competitive and other funds  (4):
  • 2006 - 2009 EGFR遺伝子変異を有する未治療進行非小細胞肺癌に対するゲフィチニブとプラチナ併用化学療法との無作為化比較試験
  • 2005 - 2007 抗癌剤投薬の適応のない、EGFR遺伝子変異陽性非小細胞肺癌に対する初回Gefitinib救済治療
  • 2003 - 2006 イリノテカン不応の既治療小細胞肺癌に対するパクリタキセル + ニムスチン(ACNU)併用第II相試験
  • 2004 - 2005 EGFR遺伝子変異陽性非小細胞肺癌に対するGefitinib治療第2相試験
Papers (133):
  • Tsukita Y, Tozuka T, Kushiro K, Hosokawa S, Sumi T, Uematsu M, Honjo O, Yamaguchi O, Asao T, Sugisaka J, et al. Immunotherapy or Chemoimmunotherapy in Older Adults With Advanced Non-Small Cell Lung Cancer. JAMA Oncology. 2024. 10. 4. 439-447
  • Jänne PA, Planchard D, Kobayashi K, Cheng Y, Lee CK, Valdiviezo N, Laktionov K, Yang TY, Yu Y, Kato T, et al. CNS Efficacy of Osimertinib With or Without Chemotherapy in Epidermal Growth Factor Receptor- Mutated Advanced Non-Small-Cell Lung Cancer. Journal of Clinical Oncology. 2024. 42. 7
  • Tozuka T, Minegishi Y, Yamaguchi O, Watanabe K, Toi Y, Saito R, Nagai Y, Tamura Y, Shoji T, Odagiri H, et al. Immunotherapy With Radiotherapy for Brain Metastases in Patients With NSCLC: NEJ060. JTO Clin Res Rep. 2024
  • Kawakado K, Tsubata Y, Hotta T, Yamasaki M, Ishikawa N, Fujitaka K, Kubota T, Kobayashi K, Isobe T. Risk Factors for Bleeding Events in Japanese Patients with Advanced Lung Cancer:. Cancers (Basel). 2024. 16. 2. 301
  • Watanabe S, Furuya N, Nakamura A, Shiihara J, Nakachi I, Tanaka H, Nakao M, Minato K, Seike M, Sasaki S, et al. A phase II study of atezolizumab with bevacizumab, carboplatin, and paclitaxel for patients with EGFR-mutated NSCLC after TKI treatment failure (NEJ043 study). European Journal of Cancer. 2024. 197. :113469-113469
more...
MISC (1):
  • Oizumi S, Takamura K, Harada T, Tachihara M, Morikawa N, Honda R, Watanabe S, Asao T, Kunisaki M, Fukuhara T, et al. Phase II study of carboplatin-paclitaxel alone or with bevacizumab in advanced sarcomatoid carcinoma of the lung: HOT1201/NEJ024. Int J Clin Oncol. 2022 Apr;27(4):676-683. 2022. 27. 4. 676-683
Books (2):
  • 「肺癌治療とQOL-臨床試験に焦点を当てて、Annual Review 2006 呼吸器」
    中外医学者 2006
  • 肺癌治療とQOL-臨床試験に焦点を当てて、Annual Review 2006 呼吸器
    中外医学者 2006
Lectures and oral presentations  (2):
  • 肺癌個化医療への道のり-NEJ 001 と 002 試験
    (第56回日本肺癌学会学術集会 2015)
  • ワークショップ7 Intergroup Study - NEJ の立場から
    (日本臨床腫瘍学会総会 2013)
Education (1):
  • 1977 - 1983 Nippon Medical School Faculty of Medicine
Professional career (1):
  • 博士(医学) (日本医科大学)
Committee career (1):
  • 2013/04 - 現在 日本肺癌学会 委員
Awards (2):
  • 2012/12 - International Research Promotion Council (IRPC) World Scientists Forum International Award - Eminent Scientist of the Year 2012.
  • 2011/04 - 文部科学大臣 科学技術賞
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page